PropertyValue
?:definition
  • A chemotherapy regimen consisting of bortezomib that may be used in the treatment of mantle cell lymphoma (MCL), plasma cell (multiple) myeloma, primary systemic light (AL) chain amyloidosis, Waldenstrom\'s macroglobulinemia (WM) and lymphoplasmacytic lymphoma (LPL).
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C5204844_NCI>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C5204844_NCI>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all